<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
Discover AGCellerate™ for LVV - a faster option to get your GMP-ready lentiviral vector product   Learn about AGCellerate

2 min read

RNA Leaders USA Congress, September 6-7

RNA Leaders USA Congress, September 6-7

Date: September 6 - 7, 2023

Location: Hynes Convention Centre, Boston, USA - Directions

Booth: #2

Event Website: https://www.lsxleaders.com/rna-leaders-usa-congress 


Join us for our live presentation & meet our team!

Eszter Békefi, a Proposal Manager at AGC Biologics, will be presenting at the event on Innovating and Producing R&D and GMP mRNA. Please join us on September 7  at 11:25 as part of the mRNA Therapeutics & Vaccines Track to hear Eszter's presentation!

Swing by our booth at the event to chat with our team or you can set up a meeting ahead of time!


You can also reach out directly to our experts attending the show

Eszter Békefi
Proposal Manager, Business Development

Email  me

PJ Priester
Director, Business Development
Email  me
Daniel McCallister
Director, Business Development
Email me

Learn about our mRNA and cell & gene therapy services

mRNA Manufacturing

AGC Biologics leveraged its 25+ years of experience in microbial, drug substance, and pDNA manufacturing to create our Messenger RNA (mRNA) service line. We manufacture high-quality mRNA in R&D and GMP grades for some of the most demanding applications in the industry today, and offer customized process development services based on your specific mRNA and host system needs.

Learn more about our mRNA services

Download our factsheet

Cell Therapy Production and Manufacturing

AGC Biologics’ cell therapy services support every stage of the product journey, from pre-clinical through commercialization. At our Milan and Longmont facilities, we can work with virtually any cell type – including Human Mesenchymal Stem Cells (hMSCs), Exosomes, CD34+, T-Cells, NK Cells, and more.  

Using the latest autologous and allogeneic methods, we help your products meet the exact specifications for patients in a clinical or commercial setting. 

Learn more about our overall cell therapy offering 

Viral Vector Production and Manufacturing 

AGC Biologics scientists have two decades of viral vector-based gene therapy expertise and specialize in adeno-associated viral vectors (AAV), lentiviral vectors (LVV), and retroviral vectors (RVV). Our sites in the U.S. and Italy have supported four commercial products. 

Our ready-to-use platform capabilities for AAV and LVV programs are built on cell factories and bioreactors using adherent and suspension processes, designed entirely in-house. 

Discover more about our viral vector services 

Plasmid DNA (pDNA) Materials 

To support your pDNA needs, AGC Biologics utilizes a customized process based on your specific plasmid and hosting system. We have extensive technical expertise in fermentation, purification, and analytics, and our highly experienced teams routinely manufacture GMP-grade pDNA materials. This work includes starting material for gene therapy, and viral vector manufacturing. 

Learn more about our Plasmid offering

Fill out the form below to request a meeting during the event


Bio Korea 2024, May 8-10

Bio Korea 2024, May 8-10

CPHI North America, May 7-9

CPHI North America, May 7-9

ASGCT Annual Meeting, May 7-11

ASGCT Annual Meeting, May 7-11